| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2011 | ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment | Lin K.-M.; Chiu Y.-F.; Tsai I.J.; Chen C.-H.; Shen W.W.; Liu S.C.; SHAO-CHUN LU ; Liu C.-Y.; Hsiao M.-C.; Tang H.-S.; Liu S.-I.; Chang L.-H.; CHI-SHIN WU ; Tsou H.-H.; Tsai M.-H.; Chen C.-Y.; Wang S.-M.; Kuo H.-W.; Hsu Y.-T.; Liu Y.-L. | Pharmacogenetics and Genomics | 72 | 70 | |
| 2000 | Characterization of Pen n 13, a major allergen from the mold Penicillium notatum | LU-PING CHOW ; Chiou S.-H.; Hsiao M.-C.; Yu C.-J.; BOR-LUEN CHIANG | Biochemical and Biophysical Research Communications | 21 | 19 | |
| 2013 | CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions | Kuo H.-W.; Liu S.C.; Tsou H.-H.; Liu S.-W.; Lin K.-M.; SHAO-CHUN LU ; Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Chen C.-H.; Lu M.-L.; Shen W.W.; Tang H.-S.; Liu S.-I.; Chang L.-H.; Wu H.-Y.; Chang Y.-S.; Yeh T.-K.; Chen A.C.; Liu Y.-L. | Pharmacogenomics | 21 | 16 | |
| 2010 | CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine | Lin K.-M.; Tsou H.-H.; Tsai I.-J.; Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Shen W.W.; Tang H.-S.; Fang C.-K.; CHI-SHIN WU ; SHAO-CHUN LU ; Kuo H.-W.; Liu S.C.; Chan H.-W.; Hsu Y.-T.; Tian J.-N.; Liu Y.-L. | Pharmacogenomics | 36 | 32 | |
| 2003 | Dopamine transporter change in drug-na?ve schizophrenia: An imaging study with 99mTc-TRODAT-1 | Hsiao M.-C.; Lin K.-J.; Liu C.-Y.; KAI-YUAN TZEN ; Yen T.-C. | Schizophrenia Research | 64 | 58 | |
| 2010 | Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response | Tsai M.-H.; Lin K.-M.; Hsiao M.-C.; Shen W.W.; Lu M.-L.; Tang H.-S.; Fang C.-K.; CHI-SHIN WU ; SHAO-CHUN LU ; Liu S.C.; Chen C.-Y.; Liu Y.-L. | Pharmacogenomics | 105 | 92 | |
| 2010 | Synthesis of thermo-sensitive nanoparticles based on poly(n- isopropylacrylamide-co-((2-dimethylamino) ethyl methacrylate)) copolymer for drug controlled release | Tsai H.-M.; Peng C.-L.; Yang S.-J.; Lin C.-F.; Hsiao M.-C.; MING-JIUM SHIEH | 7th Asian-Australasian Conference on Composite Materials 2010 | 0 |
